Skip to main content
. 2022 May 20;42(6):517–535. doi: 10.1002/cac2.12310

FIGURE 5.

FIGURE 5

Metabolic classifiers sub‐stratified NSCLC patients with different pathological responses into prognostic risk groups. The tumor (A) and stroma metabolic classifiers (B) could further stratify responder (MPR present) and non‐responder patients (MPR absent) into short‐ and long‐term survivors using the Kaplan‐Meier analysis. Abbreviations: NSCLC, non‐small cell lung cancer; MPR, major pathological response